Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Open Label Continuation Study in Moderate to Severe Psoriasis

ClinicalTrials.gov ID: NCT00626002

Public ClinicalTrials.gov record NCT00626002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 5:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-center, Open-label Continuation Study in Moderate to Severe Plaque Psoriasis in Subjects Who Completed a Preceding Psoriasis Study With ABT-874

Study identification

NCT ID
NCT00626002
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
2,301 participants

Conditions and interventions

Interventions

  • ABT-874 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Sep 30, 2011
Completion
Sep 30, 2011
Last update posted
Jan 29, 2013

2008 – 2011

United States locations

U.S. sites
98
U.S. states
33
U.S. cities
83
Facility City State ZIP Site status
Site Reference ID/Investigator# 7496 Birmingham Alabama 35205
Site Reference ID/Investigator# 8438 Birmingham Alabama 35233
Site Reference ID/Investigator# 7522 Huntsville Alabama 35801
Site Reference ID/Investigator# 7774 Scottsdale Arizona 85251
Site Reference ID/Investigator# 7435 Tucson Arizona 85710
Site Reference ID/Investigator# 7933 Little Rock Arkansas 72204
Site Reference ID/Investigator# 7234 Bakersfield California 93309
Site Reference ID/Investigator# 8249 Fresno California 93720
Site Reference ID/Investigator# 7332 Irvine California 92697
Site Reference ID/Investigator# 7239 Los Angeles California 90045
Site Reference ID/Investigator# 8390 Oceanside California 92056
Site Reference ID/Investigator# 7503 San Diego California 92103
Site Reference ID/Investigator# 7520 San Diego California 92117
Site Reference ID/Investigator# 7010 San Diego California 92123
Site Reference ID/Investigator# 10962 San Francisco California 94118
Site Reference ID/Investigator# 7334 Santa Monica California 90404
Site Reference ID/Investigator# 7793 Vallejo California 94589
Site Reference ID/Investigator# 7929 Denver Colorado 80209
Site Reference ID/Investigator# 7436 Longmont Colorado 80501
Site Reference ID/Investigator# 7521 New Haven Connecticut 06511
Site Reference ID/Investigator# 7653 Doral Florida 33166-6665
Site Reference ID/Investigator# 8341 Jacksonville Florida 32204
Site Reference ID/Investigator# 7716 Miami Florida 33136
Site Reference ID/Investigator# 7657 Miami Florida 33144
Site Reference ID/Investigator# 10841 South Miami Florida 33143
Site Reference ID/Investigator# 7893 West Palm Beach Florida 33409-3509
Site Reference ID/Investigator# 7331 Alpharetta Georgia 30022
Site Reference ID/Investigator# 9743 Atlanta Georgia 30327
Site Reference ID/Investigator# 7891 Newnan Georgia 30263
Site Reference ID/Investigator# 7932 Snellville Georgia 30078
Site Reference ID/Investigator# 8379 Arlington Heights Illinois 60005
Site Reference ID/Investigator# 8798 Maywood Illinois 60153
Site Reference ID/Investigator# 10703 Schaumburg Illinois 60194
Site Reference ID/Investigator# 6950 Skokie Illinois 60077
Site Reference ID/Investigator# 7892 West Dundee Illinois 60118
Site Reference ID/Investigator# 6933 Indianapolis Indiana 46256
Site Reference ID/Investigator# 10422 Indianapolis Indiana 46260
Site Reference ID/Investigator# 16581 Plainfield Indiana 46168
Site Reference ID/Investigator# 7992 Overland Park Kansas 66202
Site Reference ID/Investigator# 17193 Henderson Kentucky 42420
Site Reference ID/Investigator# 8528 Louisville Kentucky 40202
Site Reference ID/Investigator# 9962 Owensboro Kentucky 42303
Site Reference ID/Investigator# 8529 Andover Massachusetts 01810
Site Reference ID/Investigator# 8149 Boston Massachusetts 02111
Site Reference ID/Investigator# 9823 Detroit Michigan 48202
Site Reference ID/Investigator# 7883 Fort Gratiot Michigan 48059
Site Reference ID/Investigator# 7238 Grand Blanc Michigan 48439
Site Reference ID/Investigator# 7656 Fridley Minnesota 55432
Site Reference ID/Investigator# 6930 St Louis Missouri 63110
Site Reference ID/Investigator# 6949 St Louis Missouri 63117
Site Reference ID/Investigator# 7240 Omaha Nebraska 68131
Site Reference ID/Investigator# 9567 Omaha Nebraska 68144
Site Reference ID/Investigator# 7757 Berlin New Jersey 08009
Site Reference ID/Investigator# 7330 East Windsor New Jersey 08520
Site Reference ID/Investigator# 7882 New Brunswick New Jersey 08903
Site Reference ID/Investigator# 7455 Albuquerque New Mexico 87106
Site Reference ID/Investigator# 8078 Buffalo New York 14221
Site Reference ID/Investigator# 8392 New York New York 10016
Site Reference ID/Investigator# 8006 New York New York 10025
Site Reference ID/Investigator# 7230 New York New York 10029-6501
Site Reference ID/Investigator# 10201 New York New York 10032
Site Reference ID/Investigator# 8037 Rochester New York 14623
Site Reference ID/Investigator# 7333 Stoney Brook New York 11790
Site Reference ID/Investigator# 7434 Hickory North Carolina 28602
Site Reference ID/Investigator# 8117 Wilmington North Carolina 28401
Site Reference ID/Investigator# 9681 Winston-Salem North Carolina 27157
Site Reference ID/Investigator# 6945 Cincinnati Ohio 45219
Site Reference ID/Investigator# 23345 Cincinnati Ohio 45220
Site Reference ID/Investigator# 7044 Cleveland Ohio 44106
Site Reference ID/Investigator# 7899 Columbus Ohio 43212
Site Reference ID/Investigator# 8389 Dayton Ohio 45408
Site Reference ID/Investigator# 11181 Oklahoma City Oklahoma 73104
Site Reference ID/Investigator# 6936 Lake Oswego Oregon 97035
Site Reference ID/Investigator# 7703 Portland Oregon 97210
Site Reference ID/Investigator# 6948 Portland Oregon 97223
Site Reference ID/Investigator# 11424 Portland Oregon 97239
Site Reference ID/Investigator# 8494 Hershey Pennsylvania 17033
Site Reference ID/Investigator# 7930 Philadelphia Pennsylvania 19103
Site Reference ID/Investigator# 6934 Johnston Rhode Island 02919
Site Reference ID/Investigator# 6935 Providence Rhode Island 02903
Site Reference ID/Investigator# 7785 Greer South Carolina 29650
Site Reference ID/Investigator# 7497 Goodlettsville Tennessee 37072
Site Reference ID/Investigator# 7388 Knoxville Tennessee 37934
Site Reference ID/Investigator# 6931 Nashville Tennessee 37215
Site Reference ID/Investigator# 7684 Arlington Texas 76011
Site Reference ID/Investigator# 10842 Austin Texas 78759
Site Reference ID/Investigator# 7498 Dallas Texas 75230
Site Reference ID/Investigator# 6947 Dallas Texas 75246-1613
Site Reference ID/Investigator# 6944 Houston Texas 77030
Site Reference ID/Investigator# 7758 San Antonio Texas 78229
Site Reference ID/Investigator# 8108 San Antonio Texas 78229
Site Reference ID/Investigator# 6937 Tyler Texas 75703
Site Reference ID/Investigator# 7655 Webster Texas 77598
Site Reference ID/Investigator# 10207 Salt Lake City Utah 84132
Site Reference ID/Investigator# 6946 Norfolk Virginia 23507
Site Reference ID/Investigator# 6932 Seattle Washington 98101
Site Reference ID/Investigator# 10306 Spokane Washington 99204
Site Reference ID/Investigator# 7884 Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00626002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2013 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00626002 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →